April – September 2010
Companies are listed in alphabetical order
1 April – 30 September 2010
- Abbott Australasia
21,128k - Abbott Products (formally Solvay)
84k - Actelion 56k
- Alcon Pharmaceuticals 29k
- Allergan 47k
- AMGEN Australia 176k
- AstraZeneca 625k
- Baxter Healthcare 49k
- Bayer Australia 191k
- Biogen Idec Australia 146k
- Boehringer Ingelheim 208k
- Bristol-Myers Squibb Australia 10,437k
- Celgene Pty Ltd 40k
- CSL Limited 120k
- Eli Lilly Australia 986k
- Fresenius Kabi 102k
- Genzyme Australasia Pty Ltd 173k
- Gilead Sciences 54k
- GlaxoSmithKline Australia 613k
- iNova Pharmaceuticals 25k
- Invida Australia 10k
- Ipsen 73k
- Janssen 759k
- Lundbeck 47k
- Merck Serono 67k
- Merck Sharp & Dohme Australia 795k
- Mundipharma 128k
- Norgine 47k
- Novartis Pharmaceuticals 298k
- Novo Nordisk 231k
- Nycomed 156k
- Pfizer Australia 930k
- Roche Products 450k
- sanofi-aventis 8,374k
- Servier Laboratories 266k
- Shire Australia 31k
- Smith&Nephew 12k
- UCB Pharma 77k
Previous Educational Event Reports
Page updated: December 2011